查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1853655

按服務模式、應用程式、最終用戶和服務供應商分類的家庭出診市場—全球預測，2025-2032年

House Calls Market by Service Mode, Application, End User, Service Provider - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，家庭出診市場規模將達到 45.3 億美元，複合年成長率為 7.03%。

關鍵市場統計數據
基準年2024年 26.3億美元
預計年份：2025年 28.1億美元
預測年份 2032 45.3億美元
複合年成長率（%） 7.03%

本書清晰而有力地介紹了家庭出診作為一種永久性醫療服務模式轉變，其驅動力包括便利性、技術進步以及支付方和醫療服務提供方的重新調整。

居家醫療保健和遠距就診服務的復興標誌著醫療服務取得、提供和體驗方式的根本性轉變。病人越來越重視能夠減輕出行負擔、同時又能維持便利性、連續性和臨床品質的整合式醫療服務路徑。同時，醫療服務提供者和支付方正在嘗試將面對面評估、遠端監測和同步遠端醫療相結合的混合模式，以管理慢性病、急性病就診和術後追蹤。這些變化正在重塑整個醫療系統和獨立醫療服務提供者網路的臨床工作流程、人員配備模式和資金分配決策。

事實上，家庭出診服務已不再局限於零星的就診，而是擴展到包括電話分診和視訊臨床診療，並整合了電子健康記錄、遠距離診斷和病患報告結局工具。這種擴展為慢性病管理、術後護理和推廣等專科服務創造了新的機遇，同時也對物流、人員培養和報銷流程提出了新的要求。此外，行動連線和設備互通性的技術進步也降低了在傳統臨床環境之外進行具有臨床意義的評估的門檻。

隨著相關人員考慮後續步驟，一個核心挑戰在於如何協調臨床通訊協定、品質保證和商業性獎勵，以建立一個可擴展且永續的家庭巡診計畫。本導言為後續章節深入探討結構性變革、監管影響和最佳營運實踐奠定了基礎，並強調了隨著該領域的成熟，數據主導策略的必要性。

全面審視正在重塑就醫體驗的變革性轉變，包括技術整合、混合型醫療團隊和基於價值的獎勵。

家庭出診模式正經歷著一場變革性的轉變，其影響因素包括科技應用、病人期望以及法律規範等。在技​​術層面，高保真視訊的普及、智慧型手機的廣泛應用以及遠端監測設備的改進，使得遠端評估在更廣泛的疾病領域具有臨床意義。因此，醫療服務提供者正在重新設計診療路徑，將虛擬就診環節融入日常管理，而非僅作為門診就診的臨時替代。患者對無縫銜接、數位就診體驗的期望，也進一步推動了這一轉變，他們希望減少出行時間，並在家中即可獲得醫療服務。

在營運方面，我們看到一種趨勢，即採用混合式人員編制模式，將執業護理師、醫生和治療師融合到多學科團隊中，從而提供線上和線下兩種就診方式。這些整合模式最佳化了醫護人員的時間，增加了服務不足人口的就診機會，並為預約、病歷記錄和病情升級創建了新的工作流程。此外，技術供應商正與臨床網路合作，開發捆綁式解決方案，以簡化部署並降低小型診所的技術整合成本。

監管和報銷環境也隨之發展，催生了新的補償和醫療服務模式。隨著支付模式日益注重價值和結果，那些能夠減少不必要的急診就診、改善慢性病控制並提高患者滿意度的家庭巡診計畫有望獲得策略性投資。總而言之，這些變革表明，家庭巡診計畫正從試點階段走向成熟，成為多元化醫療服務策略的核心組成部分。

深入分析美國到 2025 年的累積關稅如何擾亂醫療設備採購，並加速靈活採購和軟體優先策略的發展。

美國近期加徵的關稅措施將持續到2025年，其累積影響正波及到醫療服務供應鏈的各個環節，尤其是醫療設備採購、醫療設備耗材和技術硬體採購。診斷設備、監控設備和患者平板電腦等進口成本的增加，迫使醫療機構和技術供應商重新評估籌資策略。許多醫療機構正在透過延長設備使用壽命、增加可維修零件的供應以及簽訂長期供應商合約來應對，以穩定單位成本並確保專案利潤。

這些壓力加速了區域採購和供應商多元化的長期趨勢。醫療系統和居家照護提供者正在尋找替代的生產合作夥伴和本地分銷商，以降低關稅帶來的成本波動風險。同時，某些硬體價格的上漲壓力也推動了軟體主導解決方案的發展，從而減少了對專用實體設備的依賴。例如，臨床醫生正在採用基於行動應用程式的評估、基於攝影機的視覺檢查和雲端基礎的分析，這些方案都可以在廣泛使用的消費級設備上運行，從而減少了對昂貴專用設備的依賴。

重要的是，不斷變化的關稅環境導致資本配置決策受到更嚴格的審查。評估新的門診就診舉措的醫療機構越來越關注整體擁有成本、供應鏈彈性和跨供應商生態系統靈活調整的能力。為此，採購團隊和臨床負責人正在專案設計初期就展開合作，以確保規範標準與可用的、不受關稅影響的採購方案相符。整體而言，關稅主導的調整促使醫療機構採取適應性策略，優先考慮門診就診價值鏈的靈活性、互通性和成本透明度。

基於詳細細分的洞察揭示了服務類型、臨床用途、最終用戶群和提供者組合如何驅動專案設計和營運重點。

對市場區隔的深入理解對於設計有效的家庭出診服務至關重要，而四個互補的維度則揭示了清晰的營運和商業意義。基於服務模式，市場研究涵蓋家庭出診、電話和視訊通話；家庭出診類別進一步細分為護士上門、醫生上門和治療師上門；視訊通話細分為桌上型視訊通話和行動視訊通話；視訊通話又細分為桌上型視訊通話和行動視訊通話。每種模式都對人員配備、排班和設備提出了獨特的要求，從而需要在臨床準確性和患者便利性之間做出權衡。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 使用穿戴式裝置和連網感測器的居家醫療監測服務需求不斷成長
  • 擴大行動醫療單位的規模，以便直接為病患提供居家急診和初級照護服務。
  • 透過線上線下相結合的混合模式提供個人化護理計劃，業務量有所成長。
  • 加強醫療網路與家庭訪視服務之間的合作，以減少再次住院。
  • 實施人工智慧驅動的日程安排和路線規劃工具，以最佳化就診效率和資源利用率
  • 監管改革促進了居家基層醫療和遠端醫療就診的報銷
  • 整合慢性病管理和家庭訪視項目，以提高患者依從性和治療效果。
  • 增加對專業上門服務機構的投資，重點關注老年人和臨終關懷居家照護服務。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：以服務模式分類的家庭出診市場

  • 家訪
    • 護士來訪
    • 醫生檢查
    • 治療師來訪
  • 電話
  • 視訊通話
    • 桌上型視訊通話
    • 行動視訊通話

第9章：按應用分類的家庭訪視市場

  • 慢性病管理
    • 慢性阻塞性肺病管理
    • 糖尿病管理
    • 高血壓管理
  • 醫療諮詢
  • 術後護理
  • 疫苗接種服務

第10章：以最終使用者分類的家庭出診市場

  • 慢性疾病患者
    • 慢性阻塞性肺病患者
    • 糖尿病患者
    • 高血壓患者
  • 老年患者
  • 兒科患者
  • 女性健康患者

第11章：按服務供應商分類的家庭出診市場

  • 護士
  • 醫生
  • 治療師
    • 職能治療師
    • 物理治療師
    • 語言聽力治療師

第12章：各地區的家庭出診市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：按群體分類的家庭出診市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：各國家庭出診市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Kindred Healthcare, Inc.
    • Amedisys, Inc.
    • LHC Group, Inc.
    • Encompass Health Corporation
    • BAYADA Home Health Care
    • AccentCare, Inc.
    • Addus HomeCare
    • Interim HealthCare, Inc.
    • BrightStar Care, LLC
    • DispatchHealth, Inc.
Product Code: MRR-8C74ADFC01A5

The House Calls Market is projected to grow by USD 4.53 billion at a CAGR of 7.03% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.63 billion
Estimated Year [2025] USD 2.81 billion
Forecast Year [2032] USD 4.53 billion
CAGR (%) 7.03%

A clear and compelling introduction that frames house calls as a durable shift in care delivery driven by convenience, technology, and payer-provider realignment

The resurgence of in-home healthcare and virtual house call services represents a fundamental reorientation of how care is accessed, delivered, and experienced. Patients increasingly prioritize convenience, continuity, and integrated care pathways that reduce travel burden while preserving clinical quality. Concurrently, providers and payers are experimenting with hybrid models that blend in-person assessment, remote monitoring, and synchronous telehealth to manage chronic conditions, acute consults, and post-operative follow-up. These dynamics are reshaping clinical workflows, staffing models, and capital allocation decisions across health systems and independent provider networks.

In practice, the house calls movement extends beyond episodic home visits to encompass phone-based triage and video-enabled clinical encounters that integrate with electronic health records, remote diagnostics, and patient-reported outcome tools. This expansion creates new opportunities for specialized services such as chronic disease management, post-operative care, and vaccination outreach while demanding new capabilities in logistics, workforce training, and reimbursement navigation. Moreover, technological advances in mobile connectivity and device interoperability are lowering barriers to delivering clinically meaningful assessments outside traditional clinical settings.

As stakeholders contemplate next steps, the central challenge lies in aligning clinical protocols, quality assurance, and commercial incentives to deliver scalable, sustainable house call programs. This introduction frames a deeper examination of the structural shifts, regulatory influences, and operational best practices that follow in subsequent sections, and it underscores the imperative for data-driven strategy as the sector matures.

Comprehensive exploration of the transformative shifts reshaping house calls including technology integration, hybrid care teams, and value-based incentives

The landscape for house calls has experienced transformative shifts that extend across technology adoption, patient expectations, and regulatory frameworks. Technologically, the normalization of high-fidelity video, widespread smartphone penetration, and improvements in remote monitoring devices have made remote assessment clinically actionable for a wider range of conditions. Consequently, providers are redesigning care pathways to embed virtual touchpoints as part of routine management rather than as ad hoc substitutes for clinic visits. This transition is reinforced by patients who now expect seamless, digitally enabled experiences that reduce travel time and permit care within the home environment.

From an operational perspective, there is a move toward hybrid staffing models that blend nurse practitioners, physicians, and therapists into multidisciplinary teams capable of delivering both in-person home visits and virtual consultations. These integrated models optimize provider time, increase access for underserved populations, and create new workflows for scheduling, documentation, and care escalation. Furthermore, partnerships between technology vendors and clinical networks have accelerated, producing bundled solutions that simplify deployment and reduce technology integration overhead for smaller provider organizations.

Regulatory and reimbursement environments have also evolved, enabling novel approaches to compensation and care delivery. As payment models increasingly emphasize value and outcomes, house call programs that demonstrate reductions in avoidable emergency department visits, improved chronic disease control, and higher patient satisfaction are positioned to capture strategic investment. Taken together, these transformative shifts indicate a maturation of house calls from experimental pilots into core components of diversified care delivery strategies.

In-depth analysis of how cumulative United States tariff measures through 2025 disrupted device sourcing and accelerated resilient procurement and software-first strategies

The cumulative impact of recent tariff actions in the United States through 2025 has reverberated across the supply chains that underpin house call services, particularly in device procurement, medical equipment availability, and technology hardware sourcing. Increased import costs for diagnostic devices, monitoring equipment, and patient-facing tablets have forced providers and technology vendors to reassess procurement strategies. Many organizations responded by extending device lifecycles, increasing repairable components, and negotiating longer-term supplier contracts to stabilize unit costs and preserve program margins.

These pressures have accelerated a longer-term trend toward regionalized sourcing and supplier diversification. Health systems and home care providers have sought alternative manufacturing partners and regional distributors to mitigate the risk of tariff-induced cost volatility. At the same time, the upward pressure on certain hardware prices has incentivized software-led solutions that reduce reliance on specialized physical devices. For example, clinicians have adopted mobile-app-based assessments, camera-enhanced visual exams, and cloud-based analytics that can operate on widely available consumer devices, thereby lowering dependency on expensive proprietary equipment.

Importantly, the tariff environment has also prompted greater scrutiny of capital allocation decisions. Institutions evaluating new house call initiatives now place stronger emphasis on total cost of ownership, supply chain resilience, and the ability to pivot between vendor ecosystems. In response, procurement teams and clinical leaders are collaborating earlier in program design to align specification standards with available, tariff-robust sourcing options. Overall, the tariff-driven adjustments have catalyzed adaptive strategies that prioritize flexibility, interoperability, and cost transparency across the house calls value chain.

Detailed segmentation-driven insights revealing how service modes, clinical applications, end-user cohorts, and provider mixes determine program design and operational priorities

A nuanced understanding of segmentation is essential to designing effective house call programs, and four complementary dimensions reveal distinct operational and commercial implications. Based on Service Mode, the market is studied across Home Visits, Phone Calls, and Video Calls; the Home Visits category is further delineated into Nurse Practitioner Visits, Physician Visits, and Therapist Visits, while Video Calls are sub-segmented into Desktop Video Calls and Mobile Video Calls. Each mode imposes unique staffing, scheduling, and equipment requirements and yields different clinical fidelity and patient convenience trade-offs.

Based on Application, the market is studied across Chronic Disease Management, Medical Consultation, Post-Operative Care, and Vaccination Services; the Chronic Disease Management category is further subdivided into COPD Management, Diabetes Management, and Hypertension Management. These application-level distinctions drive care pathways, remote monitoring protocols, and the types of patient education resources required to achieve adherence and improved outcomes. Based on End User, the market is studied across Chronic Disease Patients, Elderly Patients, Pediatric Patients, and Women's Health Patients; within Chronic Disease Patients, segmentation further differentiates COPD Patients, Diabetes Patients, and Hypertension Patients. Tailoring services to these populations requires attention to clinical complexity, caregiver involvement, and modalities of engagement.

Based on Service Provider, the market is studied across Nurse Practitioners, Physicians, and Therapists; the Therapists group is further detailed into Occupational Therapists, Physical Therapists, and Speech Therapists. Provider mix influences scope-of-practice considerations, reimbursement pathways, and training needs for delivering safe and effective in-home or virtual care. Together, these segmentation lenses offer a multidimensional blueprint for program design: matching service mode to clinical application, aligning provider capabilities to end-user needs, and selecting technology and logistics solutions that support both clinical quality and operational efficiency.

Region-specific intelligence on how the Americas, Europe Middle East & Africa, and Asia-Pacific each shape distinct house call models, regulation, and technology choices

Regional dynamics materially influence how house call services are deployed, scaled, and regulated, with distinct patterns emerging across major geographies. In the Americas, service models have evolved rapidly in response to patient demand for convenience and payer interest in avoiding high-cost acute care. Providers in urban and rural markets have both pursued hybrid approaches that integrate home visits with telehealth check-ins, while workforce constraints and varied state-level regulations have shaped the speed of program expansion.

In Europe, the Middle East & Africa, policymakers and health systems emphasize integration with primary care networks and population health initiatives. Regulatory frameworks in several jurisdictions incentivize outreach to aging populations and chronic disease cohorts, promoting the adoption of multidisciplinary teams and standardized clinical protocols. Meanwhile, infrastructure variability across the region necessitates tailored technology stacks that work reliably under diverse connectivity conditions.

In Asia-Pacific, high population density, rapid digital adoption, and government-led digital health initiatives create fertile ground for scalable telehealth and home-based services. Market participants in this region frequently prioritize mobile-first video call platforms and partnerships with local distributors to address last-mile logistics. Across all regions, interoperability, data governance, and culturally sensitive care models remain decisive factors in determining which house call approaches will succeed in the medium term.

Actionable intelligence on how leading vendors and providers are reorganizing offerings, partnerships, and clinical talent strategies to scale house call services

Key companies operating in the house calls ecosystem are responding to rising demand by evolving their product portfolios, partnership strategies, and service delivery models. Across the vendor landscape, there is a clear bifurcation between organizations that pursue vertically integrated service delivery-building clinical teams, logistics, and technology under one roof-and those that focus on modular software and platform capabilities designed to plug into existing provider infrastructures. This divergence produces different strengths: vertically integrated players excel at end-to-end patient experience design, while platform-focused vendors enable faster adoption by health systems and smaller provider groups seeking to retain existing clinical control.

Many leading organizations are investing heavily in interoperability, recognizing that seamless EHR integration and standardized data exchange are prerequisites for safe transitions of care and reliable outcome measurement. In addition, strategic partnerships with device manufacturers and third-party logistics providers are increasingly common to ensure consistent delivery of in-home equipment and to manage maintenance under constrained supply conditions. Talent strategies are also shifting: firms are expanding training programs for nurse practitioners and therapists, as well as creating new clinical playbooks for mixed-mode visits that ensure quality and reproducibility.

Collectively, these company-level moves reflect an industry-wide emphasis on modularity, clinical governance, and partnership orchestration as the core levers for scaling house call offerings while preserving patient safety and satisfaction.

Practical and prioritized recommendations for executives to operationalize house call programs, focusing on clinical alignment, procurement, interoperability, and workforce enablement

Industry leaders must act decisively to translate strategic intent into operational impact, focusing on a set of pragmatic priorities that balance short-term feasibility with long-term resilience. First, align service mode selection with the clinical application and patient cohort to avoid one-size-fits-all deployments; for example, prioritize mobile video and phone follow-ups for routine consultations while reserving in-person home visits for higher-acuity assessments and therapy sessions requiring tactile intervention. Second, establish cross-functional procurement and clinical design teams early to ensure that supply decisions, device specifications, and staffing models reflect both clinical needs and potential sourcing constraints.

Third, invest in interoperable architecture and data governance to enable care continuity across settings and measurable outcome tracking. A consistent clinical documentation standard and secure, role-based access controls will reduce variability and support downstream value-based contracting. Fourth, develop workforce development programs that upskill nurse practitioners, therapists, and community health workers in remote assessment techniques, telehealth etiquette, and escalation protocols. Finally, implement iterative pilots with clear quality metrics and patient experience benchmarks, using structured feedback loops to refine scheduling algorithms, visit durations, and escalation pathways. Taken together, these actions create a replicable playbook for organizations aiming to scale house call services while managing risk and preserving care quality.

Transparent and rigorous research methodology combining expert interviews, literature synthesis, and data triangulation to produce verifiable and operationally relevant findings

The research behind this analysis combines qualitative expert engagement with structured evidence synthesis to ensure robust, actionable findings. Primary research included in-depth interviews with clinicians, operations leaders, procurement specialists, and technology executives involved in home-based and virtual care programs, supplemented by observational reviews of care pathways and pilot program documentation. These conversations provided real-world perspectives on clinical workflows, staffing constraints, and technology integration challenges that informed the operational recommendations.

Secondary research involved systematic review of peer-reviewed clinical literature, regulatory guidance documents, and publicly available policy statements relevant to telehealth, scope of practice, and remote monitoring. Data triangulation occurred by cross-referencing primary interview themes with documented case examples and regional regulatory frameworks to validate conclusions and identify reproducible best practices. Where quantitative administrative data were available through public or partner sources, these were used to corroborate patterns in service utilization and care escalation, while ensuring that no proprietary market sizing or forecasting claims are made.

Finally, methodological rigor was maintained through iterative review cycles with clinical advisors and subject matter experts to reduce bias and ensure the recommendations reflect operational feasibility across diverse provider types and geographies. This mixed-methods approach yields findings grounded in both on-the-ground experience and published evidence.

Concise and forward-looking conclusion that synthesizes strategic imperatives for scaling safe, patient-centered, and resilient house call programs

As house calls transition from niche experiments to integral elements of care portfolios, stakeholders must calibrate strategy to a landscape defined by technological capability, regulatory change, and evolving patient expectations. The convergence of remote monitoring, high-quality video encounters, and multidisciplinary in-home teams enables richer care experiences while challenging organizations to redesign workflows, procurement practices, and training programs. Success will accrue to those who prioritize interoperability, resilient supply chains, and adaptable staffing models that match service mode to clinical need.

Moreover, the cumulative policy and trade developments of the recent period have underscored the importance of flexibility in sourcing and the value of software-forward approaches that reduce dependency on specialized hardware. Regional variance in infrastructure and regulation requires locally informed deployments rather than uniform rollouts. Finally, early investments in measurable quality frameworks and patient experience metrics will facilitate payer engagement and support transitions to value-based arrangements where appropriate. In short, the path forward demands deliberate experimentation, governance-minded scaling, and close alignment between clinical goals and operational capabilities.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising demand for in-home medical monitoring services using wearable devices and connected sensors
  • 5.2. Expansion of mobile care units providing urgent and primary care visits directly to patient homes
  • 5.3. Growth of personalized care plans delivered through virtual and in-person home visit hybrid models
  • 5.4. Increasing partnerships between healthcare networks and home call services to reduce hospital readmissions
  • 5.5. Adoption of AI-driven scheduling and routing tools to optimize house call efficiency and resource utilization
  • 5.6. Regulatory shifts encouraging reimbursement for home-based primary care and telehealth house calls
  • 5.7. Integration of chronic disease management with home visit programs to improve patient adherence and outcomes
  • 5.8. Investment growth in specialized house call providers focusing on geriatric and palliative home care services

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. House Calls Market, by Service Mode

  • 8.1. Home Visits
    • 8.1.1. Nurse Practitioner Visits
    • 8.1.2. Physician Visits
    • 8.1.3. Therapist Visits
  • 8.2. Phone Calls
  • 8.3. Video Calls
    • 8.3.1. Desktop Video Calls
    • 8.3.2. Mobile Video Calls

9. House Calls Market, by Application

  • 9.1. Chronic Disease Management
    • 9.1.1. Copd Management
    • 9.1.2. Diabetes Management
    • 9.1.3. Hypertension Management
  • 9.2. Medical Consultation
  • 9.3. Post-Operative Care
  • 9.4. Vaccination Services

10. House Calls Market, by End User

  • 10.1. Chronic Disease Patients
    • 10.1.1. Copd Patients
    • 10.1.2. Diabetes Patients
    • 10.1.3. Hypertension Patients
  • 10.2. Elderly Patients
  • 10.3. Pediatric Patients
  • 10.4. Women's Health Patients

11. House Calls Market, by Service Provider

  • 11.1. Nurse Practitioners
  • 11.2. Physicians
  • 11.3. Therapists
    • 11.3.1. Occupational Therapists
    • 11.3.2. Physical Therapists
    • 11.3.3. Speech Therapists

12. House Calls Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. House Calls Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. House Calls Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Kindred Healthcare, Inc.
    • 15.3.2. Amedisys, Inc.
    • 15.3.3. LHC Group, Inc.
    • 15.3.4. Encompass Health Corporation
    • 15.3.5. BAYADA Home Health Care
    • 15.3.6. AccentCare, Inc.
    • 15.3.7. Addus HomeCare
    • 15.3.8. Interim HealthCare, Inc.
    • 15.3.9. BrightStar Care, LLC
    • 15.3.10. DispatchHealth, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL HOUSE CALLS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HOUSE CALLS MARKET SIZE, BY SERVICE MODE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL HOUSE CALLS MARKET SIZE, BY SERVICE MODE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL HOUSE CALLS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL HOUSE CALLS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HOUSE CALLS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL HOUSE CALLS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HOUSE CALLS MARKET SIZE, BY SERVICE PROVIDER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL HOUSE CALLS MARKET SIZE, BY SERVICE PROVIDER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HOUSE CALLS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS HOUSE CALLS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA HOUSE CALLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA HOUSE CALLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA HOUSE CALLS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE HOUSE CALLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST HOUSE CALLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA HOUSE CALLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC HOUSE CALLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL HOUSE CALLS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN HOUSE CALLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC HOUSE CALLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION HOUSE CALLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS HOUSE CALLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 HOUSE CALLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO HOUSE CALLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL HOUSE CALLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. HOUSE CALLS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. HOUSE CALLS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. HOUSE CALLS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL HOUSE CALLS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL HOUSE CALLS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL HOUSE CALLS MARKET SIZE, BY SERVICE MODE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL HOUSE CALLS MARKET SIZE, BY SERVICE MODE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL HOUSE CALLS MARKET SIZE, BY HOME VISITS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL HOUSE CALLS MARKET SIZE, BY HOME VISITS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL HOUSE CALLS MARKET SIZE, BY HOME VISITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL HOUSE CALLS MARKET SIZE, BY HOME VISITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL HOUSE CALLS MARKET SIZE, BY HOME VISITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL HOUSE CALLS MARKET SIZE, BY HOME VISITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL HOUSE CALLS MARKET SIZE, BY HOME VISITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL HOUSE CALLS MARKET SIZE, BY HOME VISITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL HOUSE CALLS MARKET SIZE, BY NURSE PRACTITIONER VISITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL HOUSE CALLS MARKET SIZE, BY NURSE PRACTITIONER VISITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL HOUSE CALLS MARKET SIZE, BY NURSE PRACTITIONER VISITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL HOUSE CALLS MARKET SIZE, BY NURSE PRACTITIONER VISITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL HOUSE CALLS MARKET SIZE, BY NURSE PRACTITIONER VISITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL HOUSE CALLS MARKET SIZE, BY NURSE PRACTITIONER VISITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL HOUSE CALLS MARKET SIZE, BY PHYSICIAN VISITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL HOUSE CALLS MARKET SIZE, BY PHYSICIAN VISITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL HOUSE CALLS MARKET SIZE, BY PHYSICIAN VISITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL HOUSE CALLS MARKET SIZE, BY PHYSICIAN VISITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL HOUSE CALLS MARKET SIZE, BY PHYSICIAN VISITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL HOUSE CALLS MARKET SIZE, BY PHYSICIAN VISITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL HOUSE CALLS MARKET SIZE, BY THERAPIST VISITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL HOUSE CALLS MARKET SIZE, BY THERAPIST VISITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL HOUSE CALLS MARKET SIZE, BY THERAPIST VISITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL HOUSE CALLS MARKET SIZE, BY THERAPIST VISITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL HOUSE CALLS MARKET SIZE, BY THERAPIST VISITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL HOUSE CALLS MARKET SIZE, BY THERAPIST VISITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL HOUSE CALLS MARKET SIZE, BY PHONE CALLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL HOUSE CALLS MARKET SIZE, BY PHONE CALLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL HOUSE CALLS MARKET SIZE, BY PHONE CALLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL HOUSE CALLS MARKET SIZE, BY PHONE CALLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL HOUSE CALLS MARKET SIZE, BY PHONE CALLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL HOUSE CALLS MARKET SIZE, BY PHONE CALLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL HOUSE CALLS MARKET SIZE, BY VIDEO CALLS, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL HOUSE CALLS MARKET SIZE, BY VIDEO CALLS, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL HOUSE CALLS MARKET SIZE, BY VIDEO CALLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL HOUSE CALLS MARKET SIZE, BY VIDEO CALLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL HOUSE CALLS MARKET SIZE, BY VIDEO CALLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL HOUSE CALLS MARKET SIZE, BY VIDEO CALLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL HOUSE CALLS MARKET SIZE, BY VIDEO CALLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL HOUSE CALLS MARKET SIZE, BY VIDEO CALLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL HOUSE CALLS MARKET SIZE, BY DESKTOP VIDEO CALLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL HOUSE CALLS MARKET SIZE, BY DESKTOP VIDEO CALLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL HOUSE CALLS MARKET SIZE, BY DESKTOP VIDEO CALLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL HOUSE CALLS MARKET SIZE, BY DESKTOP VIDEO CALLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL HOUSE CALLS MARKET SIZE, BY DESKTOP VIDEO CALLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL HOUSE CALLS MARKET SIZE, BY DESKTOP VIDEO CALLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL HOUSE CALLS MARKET SIZE, BY MOBILE VIDEO CALLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL HOUSE CALLS MARKET SIZE, BY MOBILE VIDEO CALLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL HOUSE CALLS MARKET SIZE, BY MOBILE VIDEO CALLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL HOUSE CALLS MARKET SIZE, BY MOBILE VIDEO CALLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL HOUSE CALLS MARKET SIZE, BY MOBILE VIDEO CALLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL HOUSE CALLS MARKET SIZE, BY MOBILE VIDEO CALLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL HOUSE CALLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL HOUSE CALLS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL HOUSE CALLS MARKET SIZE, BY COPD MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL HOUSE CALLS MARKET SIZE, BY COPD MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL HOUSE CALLS MARKET SIZE, BY COPD MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL HOUSE CALLS MARKET SIZE, BY COPD MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL HOUSE CALLS MARKET SIZE, BY COPD MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL HOUSE CALLS MARKET SIZE, BY COPD MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL HOUSE CALLS MARKET SIZE, BY DIABETES MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL HOUSE CALLS MARKET SIZE, BY DIABETES MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL HOUSE CALLS MARKET SIZE, BY DIABETES MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL HOUSE CALLS MARKET SIZE, BY DIABETES MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL HOUSE CALLS MARKET SIZE, BY DIABETES MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL HOUSE CALLS MARKET SIZE, BY DIABETES MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL HOUSE CALLS MARKET SIZE, BY HYPERTENSION MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL HOUSE CALLS MARKET SIZE, BY HYPERTENSION MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL HOUSE CALLS MARKET SIZE, BY HYPERTENSION MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL HOUSE CALLS MARKET SIZE, BY HYPERTENSION MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL HOUSE CALLS MARKET SIZE, BY HYPERTENSION MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL HOUSE CALLS MARKET SIZE, BY HYPERTENSION MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL HOUSE CALLS MARKET SIZE, BY MEDICAL CONSULTATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL HOUSE CALLS MARKET SIZE, BY MEDICAL CONSULTATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL HOUSE CALLS MARKET SIZE, BY MEDICAL CONSULTATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL HOUSE CALLS MARKET SIZE, BY MEDICAL CONSULTATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL HOUSE CALLS MARKET SIZE, BY MEDICAL CONSULTATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL HOUSE CALLS MARKET SIZE, BY MEDICAL CONSULTATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL HOUSE CALLS MARKET SIZE, BY POST-OPERATIVE CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL HOUSE CALLS MARKET SIZE, BY POST-OPERATIVE CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL HOUSE CALLS MARKET SIZE, BY POST-OPERATIVE CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL HOUSE CALLS MARKET SIZE, BY POST-OPERATIVE CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL HOUSE CALLS MARKET SIZE, BY POST-OPERATIVE CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL HOUSE CALLS MARKET SIZE, BY POST-OPERATIVE CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL HOUSE CALLS MARKET SIZE, BY VACCINATION SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL HOUSE CALLS MARKET SIZE, BY VACCINATION SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL HOUSE CALLS MARKET SIZE, BY VACCINATION SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL HOUSE CALLS MARKET SIZE, BY VACCINATION SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL HOUSE CALLS MARKET SIZE, BY VACCINATION SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL HOUSE CALLS MARKET SIZE, BY VACCINATION SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL HOUSE CALLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL HOUSE CALLS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE PATIENTS, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE PATIENTS, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE PATIENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE PATIENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE PATIENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE PATIENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE PATIENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE PATIENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL HOUSE CALLS MARKET SIZE, BY COPD PATIENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL HOUSE CALLS MARKET SIZE, BY COPD PATIENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL HOUSE CALLS MARKET SIZE, BY COPD PATIENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL HOUSE CALLS MARKET SIZE, BY COPD PATIENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL HOUSE CALLS MARKET SIZE, BY COPD PATIENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL HOUSE CALLS MARKET SIZE, BY COPD PATIENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL HOUSE CALLS MARKET SIZE, BY DIABETES PATIENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL HOUSE CALLS MARKET SIZE, BY DIABETES PATIENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL HOUSE CALLS MARKET SIZE, BY DIABETES PATIENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL HOUSE CALLS MARKET SIZE, BY DIABETES PATIENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL HOUSE CALLS MARKET SIZE, BY DIABETES PATIENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL HOUSE CALLS MARKET SIZE, BY DIABETES PATIENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL HOUSE CALLS MARKET SIZE, BY HYPERTENSION PATIENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL HOUSE CALLS MARKET SIZE, BY HYPERTENSION PATIENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL HOUSE CALLS MARKET SIZE, BY HYPERTENSION PATIENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL HOUSE CALLS MARKET SIZE, BY HYPERTENSION PATIENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL HOUSE CALLS MARKET SIZE, BY HYPERTENSION PATIENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL HOUSE CALLS MARKET SIZE, BY HYPERTENSION PATIENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL HOUSE CALLS MARKET SIZE, BY ELDERLY PATIENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL HOUSE CALLS MARKET SIZE, BY ELDERLY PATIENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL HOUSE CALLS MARKET SIZE, BY ELDERLY PATIENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL HOUSE CALLS MARKET SIZE, BY ELDERLY PATIENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL HOUSE CALLS MARKET SIZE, BY ELDERLY PATIENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL HOUSE CALLS MARKET SIZE, BY ELDERLY PATIENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL HOUSE CALLS MARKET SIZE, BY PEDIATRIC PATIENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL HOUSE CALLS MARKET SIZE, BY PEDIATRIC PATIENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL HOUSE CALLS MARKET SIZE, BY PEDIATRIC PATIENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL HOUSE CALLS MARKET SIZE, BY PEDIATRIC PATIENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL HOUSE CALLS MARKET SIZE, BY PEDIATRIC PATIENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL HOUSE CALLS MARKET SIZE, BY PEDIATRIC PATIENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL HOUSE CALLS MARKET SIZE, BY WOMEN'S HEALTH PATIENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL HOUSE CALLS MARKET SIZE, BY WOMEN'S HEALTH PATIENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL HOUSE CALLS MARKET SIZE, BY WOMEN'S HEALTH PATIENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL HOUSE CALLS MARKET SIZE, BY WOMEN'S HEALTH PATIENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL HOUSE CALLS MARKET SIZE, BY WOMEN'S HEALTH PATIENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL HOUSE CALLS MARKET SIZE, BY WOMEN'S HEALTH PATIENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL HOUSE CALLS MARKET SIZE, BY SERVICE PROVIDER, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL HOUSE CALLS MARKET SIZE, BY SERVICE PROVIDER, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL HOUSE CALLS MARKET SIZE, BY NURSE PRACTITIONERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL HOUSE CALLS MARKET SIZE, BY NURSE PRACTITIONERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL HOUSE CALLS MARKET SIZE, BY NURSE PRACTITIONERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL HOUSE CALLS MARKET SIZE, BY NURSE PRACTITIONERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL HOUSE CALLS MARKET SIZE, BY NURSE PRACTITIONERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL HOUSE CALLS MARKET SIZE, BY NURSE PRACTITIONERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL HOUSE CALLS MARKET SIZE, BY PHYSICIANS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL HOUSE CALLS MARKET SIZE, BY PHYSICIANS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL HOUSE CALLS MARKET SIZE, BY PHYSICIANS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL HOUSE CALLS MARKET SIZE, BY PHYSICIANS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL HOUSE CALLS MARKET SIZE, BY PHYSICIANS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL HOUSE CALLS MARKET SIZE, BY PHYSICIANS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL HOUSE CALLS MARKET SIZE, BY THERAPISTS, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL HOUSE CALLS MARKET SIZE, BY THERAPISTS, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL HOUSE CALLS MARKET SIZE, BY THERAPISTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL HOUSE CALLS MARKET SIZE, BY THERAPISTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL HOUSE CALLS MARKET SIZE, BY THERAPISTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL HOUSE CALLS MARKET SIZE, BY THERAPISTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL HOUSE CALLS MARKET SIZE, BY THERAPISTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL HOUSE CALLS MARKET SIZE, BY THERAPISTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL HOUSE CALLS MARKET SIZE, BY OCCUPATIONAL THERAPISTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL HOUSE CALLS MARKET SIZE, BY OCCUPATIONAL THERAPISTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL HOUSE CALLS MARKET SIZE, BY OCCUPATIONAL THERAPISTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL HOUSE CALLS MARKET SIZE, BY OCCUPATIONAL THERAPISTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL HOUSE CALLS MARKET SIZE, BY OCCUPATIONAL THERAPISTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL HOUSE CALLS MARKET SIZE, BY OCCUPATIONAL THERAPISTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL HOUSE CALLS MARKET SIZE, BY PHYSICAL THERAPISTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL HOUSE CALLS MARKET SIZE, BY PHYSICAL THERAPISTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL HOUSE CALLS MARKET SIZE, BY PHYSICAL THERAPISTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL HOUSE CALLS MARKET SIZE, BY PHYSICAL THERAPISTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL HOUSE CALLS MARKET SIZE, BY PHYSICAL THERAPISTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL HOUSE CALLS MARKET SIZE, BY PHYSICAL THERAPISTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL HOUSE CALLS MARKET SIZE, BY SPEECH THERAPISTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL HOUSE CALLS MARKET SIZE, BY SPEECH THERAPISTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL HOUSE CALLS MARKET SIZE, BY SPEECH THERAPISTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL HOUSE CALLS MARKET SIZE, BY SPEECH THERAPISTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL HOUSE CALLS MARKET SIZE, BY SPEECH THERAPISTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL HOUSE CALLS MARKET SIZE, BY SPEECH THERAPISTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL HOUSE CALLS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL HOUSE CALLS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS HOUSE CALLS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS HOUSE CALLS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS HOUSE CALLS MARKET SIZE, BY SERVICE MODE, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS HOUSE CALLS MARKET SIZE, BY SERVICE MODE, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS HOUSE CALLS MARKET SIZE, BY HOME VISITS, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS HOUSE CALLS MARKET SIZE, BY HOME VISITS, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS HOUSE CALLS MARKET SIZE, BY VIDEO CALLS, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS HOUSE CALLS MARKET SIZE, BY VIDEO CALLS, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS HOUSE CALLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS HOUSE CALLS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS HOUSE CALLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS HOUSE CALLS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE PATIENTS, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE PATIENTS, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS HOUSE CALLS MARKET SIZE, BY SERVICE PROVIDER, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS HOUSE CALLS MARKET SIZE, BY SERVICE PROVIDER, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS HOUSE CALLS MARKET SIZE, BY THERAPISTS, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS HOUSE CALLS MARKET SIZE, BY THERAPISTS, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA HOUSE CALLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA HOUSE CALLS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA HOUSE CALLS MARKET SIZE, BY SERVICE MODE, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA HOUSE CALLS MARKET SIZE, BY SERVICE MODE, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA HOUSE CALLS MARKET SIZE, BY HOME VISITS, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA HOUSE CALLS MARKET SIZE, BY HOME VISITS, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA HOUSE CALLS MARKET SIZE, BY VIDEO CALLS, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA HOUSE CALLS MARKET SIZE, BY VIDEO CALLS, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA HOUSE CALLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA HOUSE CALLS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA HOUSE CALLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA HOUSE CALLS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE PATIENTS, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE PATIENTS, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA HOUSE CALLS MARKET SIZE, BY SERVICE PROVIDER, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA HOUSE CALLS MARKET SIZE, BY SERVICE PROVIDER, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA HOUSE CALLS MARKET SIZE, BY THERAPISTS, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA HOUSE CALLS MARKET SIZE, BY THERAPISTS, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA HOUSE CALLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA HOUSE CALLS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA HOUSE CALLS MARKET SIZE, BY SERVICE MODE, 2018-2024 (USD MILLION)
  • TABLE 236. LATIN AMERICA HOUSE CALLS MARKET SIZE, BY SERVICE MODE, 2025-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA HOUSE CALLS MARKET SIZE, BY HOME VISITS, 2018-2024 (USD MILLION)
  • TABLE 238. LATIN AMERICA HOUSE CALLS MARKET SIZE, BY HOME VISITS, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA HOUSE CALLS MARKET SIZE, BY VIDEO CALLS, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA HOUSE CALLS MARKET SIZE, BY VIDEO CALLS, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA HOUSE CALLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA HOUSE CALLS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA HOUSE CALLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA HOUSE CALLS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE PATIENTS, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE PATIENTS, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA HOUSE CALLS MARKET SIZE, BY SERVICE PROVIDER, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA HOUSE CALLS MARKET SIZE, BY SERVICE PROVIDER, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA HOUSE CALLS MARKET SIZE, BY THERAPISTS, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA HOUSE CALLS MARKET SIZE, BY THERAPISTS, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA HOUSE CALLS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA HOUSE CALLS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA HOUSE CALLS MARKET SIZE, BY SERVICE MODE, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA HOUSE CALLS MARKET SIZE, BY SERVICE MODE, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA HOUSE CALLS MARKET SIZE, BY HOME VISITS, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA HOUSE CALLS MARKET SIZE, BY HOME VISITS, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA HOUSE CALLS MARKET SIZE, BY VIDEO CALLS, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA HOUSE CALLS MARKET SIZE, BY VIDEO CALLS, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA HOUSE CALLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA HOUSE CALLS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA HOUSE CALLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA HOUSE CALLS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE PATIENTS, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE PATIENTS, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA HOUSE CALLS MARKET SIZE, BY SERVICE PROVIDER, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA HOUSE CALLS MARKET SIZE, BY SERVICE PROVIDER, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA HOUSE CALLS MARKET SIZE, BY THERAPISTS, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA HOUSE CALLS MARKET SIZE, BY THERAPISTS, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE HOUSE CALLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE HOUSE CALLS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE HOUSE CALLS MARKET SIZE, BY SERVICE MODE, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE HOUSE CALLS MARKET SIZE, BY SERVICE MODE, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE HOUSE CALLS MARKET SIZE, BY HOME VISITS, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE HOUSE CALLS MARKET SIZE, BY HOME VISITS, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE HOUSE CALLS MARKET SIZE, BY VIDEO CALLS, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE HOUSE CALLS MARKET SIZE, BY VIDEO CALLS, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE HOUSE CALLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE HOUSE CALLS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE HOUSE CALLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE HOUSE CALLS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE PATIENTS, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE PATIENTS, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE HOUSE CALLS MARKET SIZE, BY SERVICE PROVIDER, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE HOUSE CALLS MARKET SIZE, BY SERVICE PROVIDER, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE HOUSE CALLS MARKET SIZE, BY THERAPISTS, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE HOUSE CALLS MARKET SIZE, BY THERAPISTS, 2025-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST HOUSE CALLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. MIDDLE EAST HOUSE CALLS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST HOUSE CALLS MARKET SIZE, BY SERVICE MODE, 2018-2024 (USD MILLION)
  • TABLE 296. MIDDLE EAST HOUSE CALLS MARKET SIZE, BY SERVICE MODE, 2025-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST HOUSE CALLS MARKET SIZE, BY HOME VISITS, 2018-2024 (USD MILLION)
  • TABLE 298. MIDDLE EAST HOUSE CALLS MARKET SIZE, BY HOME VISITS, 2025-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST HOUSE CALLS MARKET SIZE, BY VIDEO CALLS, 2018-2024 (USD MILLION)
  • TABLE 300. MIDDLE EAST HOUSE CALLS MARKET SIZE, BY VIDEO CALLS, 2025-2032 (USD MILLION)
  • TABLE 301. MIDDLE EAST HOUSE CALLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. MIDDLE EAST HOUSE CALLS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 303. MIDDLE EAST HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 304. MIDDLE EAST HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 305. MIDDLE EAST HOUSE CALLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 306. MIDDLE EAST HOUSE CALLS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 307. MIDDLE EAST HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE PATIENTS, 2018-2024 (USD MILLION)
  • TABLE 308. MIDDLE EAST HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE PATIENTS, 2025-2032 (USD MILLION)
  • TABLE 309. MIDDLE EAST HOUSE CALLS MARKET SIZE, BY SERVICE PROVIDER, 2018-2024 (USD MILLION)
  • TABLE 310. MIDDLE EAST HOUSE CALLS MARKET SIZE, BY SERVICE PROVIDER, 2025-2032 (USD MILLION)
  • TABLE 311. MIDDLE EAST HOUSE CALLS MARKET SIZE, BY THERAPISTS, 2018-2024 (USD MILLION)
  • TABLE 312. MIDDLE EAST HOUSE CALLS MARKET SIZE, BY THERAPISTS, 2025-2032 (USD MILLION)
  • TABLE 313. AFRICA HOUSE CALLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. AFRICA HOUSE CALLS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. AFRICA HOUSE CALLS MARKET SIZE, BY SERVICE MODE, 2018-2024 (USD MILLION)
  • TABLE 316. AFRICA HOUSE CALLS MARKET SIZE, BY SERVICE MODE, 2025-2032 (USD MILLION)
  • TABLE 317. AFRICA HOUSE CALLS MARKET SIZE, BY HOME VISITS, 2018-2024 (USD MILLION)
  • TABLE 318. AFRICA HOUSE CALLS MARKET SIZE, BY HOME VISITS, 2025-2032 (USD MILLION)
  • TABLE 319. AFRICA HOUSE CALLS MARKET SIZE, BY VIDEO CALLS, 2018-2024 (USD MILLION)
  • TABLE 320. AFRICA HOUSE CALLS MARKET SIZE, BY VIDEO CALLS, 2025-2032 (USD MILLION)
  • TABLE 321. AFRICA HOUSE CALLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 322. AFRICA HOUSE CALLS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 323. AFRICA HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 324. AFRICA HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 325. AFRICA HOUSE CALLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 326. AFRICA HOUSE CALLS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 327. AFRICA HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE PATIENTS, 2018-2024 (USD MILLION)
  • TABLE 328. AFRICA HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE PATIENTS, 2025-2032 (USD MILLION)
  • TABLE 329. AFRICA HOUSE CALLS MARKET SIZE, BY SERVICE PROVIDER, 2018-2024 (USD MILLION)
  • TABLE 330. AFRICA HOUSE CALLS MARKET SIZE, BY SERVICE PROVIDER, 2025-2032 (USD MILLION)
  • TABLE 331. AFRICA HOUSE CALLS MARKET SIZE, BY THERAPISTS, 2018-2024 (USD MILLION)
  • TABLE 332. AFRICA HOUSE CALLS MARKET SIZE, BY THERAPISTS, 2025-2032 (USD MILLION)
  • TABLE 333. ASIA-PACIFIC HOUSE CALLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 334. ASIA-PACIFIC HOUSE CALLS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 335. ASIA-PACIFIC HOUSE CALLS MARKET SIZE, BY SERVICE MODE, 2018-2024 (USD MILLION)
  • TABLE 336. ASIA-PACIFIC HOUSE CALLS MARKET SIZE, BY SERVICE MODE, 2025-2032 (USD MILLION)
  • TABLE 337. ASIA-PACIFIC HOUSE CALLS MARKET SIZE, BY HOME VISITS, 2018-2024 (USD MILLION)
  • TABLE 338. ASIA-PACIFIC HOUSE CALLS MARKET SIZE, BY HOME VISITS, 2025-2032 (USD MILLION)
  • TABLE 339. ASIA-PACIFIC HOUSE CALLS MARKET SIZE, BY VIDEO CALLS, 2018-2024 (USD MILLION)
  • TABLE 340. ASIA-PACIFIC HOUSE CALLS MARKET SIZE, BY VIDEO CALLS, 2025-2032 (USD MILLION)
  • TABLE 341. ASIA-PACIFIC HOUSE CALLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 342. ASIA-PACIFIC HOUSE CALLS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 343. ASIA-PACIFIC HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 344. ASIA-PACIFIC HOUSE CALLS MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 345. ASIA-PACIFIC HOUSE CALLS